UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer’s disease

European journal of clinical pharmacology, 2016-06, Vol.72 (6), p.711-717

2016

Volltextzugriff (PDF)

A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy

Clinical pharmacology and therapeutics, 2007-04, Vol.81 (4), p.529-538

2007

Volltextzugriff (PDF)

A Pharmacometric Model Describing the Relationship Between Warfarin Dose and INR Response With Respect to Variations in CYP2C9, VKORC1, and Age

Clinical pharmacology and therapeutics, 2010-06, Vol.87 (6), p.727-734

2010

Volltextzugriff (PDF)

Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer

British journal of cancer, 2009-05, Vol.100 (10), p.1549-1557

2009

Volltextzugriff (PDF)

Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms

The pharmacogenomics journal, 2017-12, Vol.17 (6), p.494-500

2017

Volltextzugriff (PDF)

Cytochrome P450 1A2 is a Major Determinant of Lidocaine Metabolism in Vivo: Effects of Liver Function

Clinical pharmacology and therapeutics, 2004-01, Vol.75 (1), p.80-88

2004

Volltextzugriff (PDF)

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease

British journal of haematology, 2008-10, Vol.143 (1), p.107-114

2008

Volltextzugriff (PDF)

Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancer

Annals of oncology, 2006-11, Vol.17 (11), p.1656-1660

2006

Volltextzugriff (PDF)

Severe phenytoin intoxication in a subject homozygous for CYP2C93

Clinical pharmacology and therapeutics, 2001-10, Vol.70 (4), p.391-394

Brandolese, R

2001

Volltextzugriff (PDF)

A novel G C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele

The pharmacogenomics journal, 2006-11, Vol.6 (6), p.421-424

2006

Volltextzugriff (PDF)

Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function

British journal of clinical pharmacology, 2003-01, Vol.55 (1), p.86-93

2003

Volltextzugriff (PDF)

A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty

Journal of thrombosis and thrombolysis, 2011-02, Vol.31 (2), p.233-234

2011

Volltextzugriff (PDF)

Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers

British journal of clinical pharmacology, 1998-12, Vol.46 (6), p.605-609

1998

Volltextzugriff (PDF)

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance

Clinical pharmacology and therapeutics, 2002-12, Vol.72 (6), p.702-710

2002

Volltextzugriff (PDF)

Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis

Clinical nephrology, 1999-06, Vol.51 (6), p.341

1999

Volltextzugriff (PDF)

Perioperative Analgesic Efficacy and Plasma Concentrations of S(+)-Ketamine in Continuous Epidural Infusion During Thoracic Surgery

Anesthesia and analgesia, 2013-06, Vol.116 (6), p.1371-1375

2013

Volltextzugriff (PDF)

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

Haematologica (Roma), 2010-08, Vol.95 (8), p.1366-1372

2010

Volltextzugriff (PDF)

Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers

European journal of clinical pharmacology, 1993-11, Vol.45 (4), p.353-356

1993

Volltextzugriff (PDF)

Oral metronomic Vinorelbine (OMV) in elderly pts with advanced NSCLC: pharmacokinetics and clinical outcome

Annals of oncology, 2016-09, Vol.27, p.iv6

2016

Volltextzugriff (PDF)

Diagnostic Value of Plasma Cystatin C as a Glomerular Filtration Marker in Decompensated Liver Cirrhosis

Clinical chemistry (Baltimore, Md.), 2002-06, Vol.48 (6), p.850-858

2002

Volltextzugriff (PDF)

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

Blood, 2002-01, Vol.99 (1), p.180-184

2002

Volltextzugriff (PDF)

EFFECTS OF CARDIO-PULMONARY BYPASS ON VANCOMYCIN PLASMA CONCENTRATION DECAY

Pharmacological research, 1998-10, Vol.38 (4), p.275-278

1998

Volltextzugriff (PDF)

Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine

Clinical pharmacology and therapeutics, 2006-05, Vol.79 (5), p.489-499

2006

Volltextzugriff (PDF)

Vasorelaxant properties of norbormide, a selective vasoconstrictor agent for the rat microvasculature

British journal of pharmacology, 1996-03, Vol.117 (6), p.1041-1046

1996

Volltextzugriff (PDF)

Relationships between body composition parameters and fluorouracil pharmacokinetics

British journal of clinical pharmacology, 2002-08, Vol.54 (2), p.131-139

2002

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(140)
Tagungsberichte
(2)

Sprache

Englisch
(122)
Italienisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer’s disease

A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy

A Pharmacometric Model Describing the Relationship Between Warfarin Dose and INR Response With Respect to Variations in CYP2C9, VKORC1, and Age

Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer

Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms

Cytochrome P450 1A2 is a Major Determinant of Lidocaine Metabolism in Vivo: Effects of Liver Function

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease

Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancer

Severe phenytoin intoxication in a subject homozygous for CYP2C93

A novel G C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele

Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function

A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty

Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance

Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis

Perioperative Analgesic Efficacy and Plasma Concentrations of S(+)-Ketamine in Continuous Epidural Infusion During Thoracic Surgery

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers

Oral metronomic Vinorelbine (OMV) in elderly pts with advanced NSCLC: pharmacokinetics and clinical outcome

Diagnostic Value of Plasma Cystatin C as a Glomerular Filtration Marker in Decompensated Liver Cirrhosis

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

EFFECTS OF CARDIO-PULMONARY BYPASS ON VANCOMYCIN PLASMA CONCENTRATION DECAY

Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine

Vasorelaxant properties of norbormide, a selective vasoconstrictor agent for the rat microvasculature

Relationships between body composition parameters and fluorouracil pharmacokinetics

Suchergebnisse filtern